Tuoxin Pharmaceutical Group (301089.SZ) plans to invest 420 million yuan in the construction project of a biological manufacturing base for raw materials for pharmaceuticals and health dietary supplements.

Tuoxin Pharmaceutical Group (301089.SZ) announced that its subsidiary Tuoxin Pharmaceutical Group (Inner Mongolia) Co., Ltd. (hereinafter referred to as the "Party B") intends to sign an "Investment Agreement for the Construction of the Raw Material Medicine and Health Dietary Supplement Biomanufacturing Base Project of Tuoxin Pharmaceutical Group (Inner Mongolia) Co., Ltd. in Togto County, Inner Mongolia Autonomous Region" with the Togto County People's Government of Inner Mongolia Autonomous Region (hereinafter referred to as the "Party A"). The total investment of the project is 420 million yuan, with around 300 million yuan allocated for fixed asset investment. The construction of this investment project can fully leverage the geographical location advantages and resource endowment of Togto County: on one hand, it will lay a solid foundation for the company to establish a large-scale, standardized production base, creating favorable conditions for efficient research and production activities; on the other hand, the abundant local energy resources will directly help the company reduce production costs and further expand profit margins. After the project is completed and put into operation, it will effectively improve the company's industrial chain layout, consolidate its market competitive position, and continuously enhance its core profitability and sustainable development capabilities.